| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3197064 | International Journal of Women's Dermatology | 2016 | 8 Pages |
Abstract
Dermatologists should be aware that autoantibody formation may occur after the initiation of biologic therapy. This phenomenon has been referred to as immunogenicity and biologic fatigue. Because of this, patients may experience loss of clinical efficacy to a particular drug. To combat this phenomenon, low-dose immunomodulators may be used in hopes of preventing autoantibodies. We review the current literature and provide a basic treatment algorithm for patients with moderate to severe psoriasis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Collin M. Blattner, Soham P. Chaudhari, John Young III, Jenny E. Murase,